|
| 36166093 | Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma. | Clin Cancer Res | 2023 |
| 36166093 | Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma. | Clin Cancer Res | 2023 |
| 37659660 | Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. | Radiother Oncol | 2023 |
| 37647056 | Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma. | JAMA Dermatol | 2023 |
| 37804122 | Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). | Pigment Cell Melanoma Res | 2023 |
| 37149545 | Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma. | Ann Surg Oncol | 2023 |
| 36510640 | Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. | Neuro Oncol | 2023 |
| 36894629 | Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma. | Nature | 2023 |
| 37072748 | The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022. | J Transl Med | 2023 |
| 37015331 | Letter to the Editor: Re: Reimagining Cancer Staging in the Era of Evolutionary Oncology. | J Natl Compr Canc Netw | 2023 |
| 37010038 | Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management. | J Surg Oncol | 2023 |
| 36627494 | Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. | Nature | 2023 |
| 37509290 | Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma. | Cancers (Basel) | 2023 |
| 37507765 | Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy). | J Transl Med | 2023 |
| 37499671 | Cutaneous melanoma. | Lancet | 2023 |
| 37493893 | Top Melanoma Articles from 2021 to Inform Your Cancer Practice. | Ann Surg Oncol | 2023 |
| 37162402 | Mitotic rate in primary cutaneous melanoma: Cell division matters. | Cancer | 2023 |
| 37804122 | Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). | Pigment Cell Melanoma Res | 2023 |
| 37659660 | Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. | Radiother Oncol | 2023 |
| 37509290 | Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma. | Cancers (Basel) | 2023 |
| 37507765 | Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy). | J Transl Med | 2023 |
| 37647056 | Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma. | JAMA Dermatol | 2023 |
| 37499671 | Cutaneous melanoma. | Lancet | 2023 |
| 37493893 | Top Melanoma Articles from 2021 to Inform Your Cancer Practice. | Ann Surg Oncol | 2023 |
| 37149545 | Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma. | Ann Surg Oncol | 2023 |
| 37015331 | Letter to the Editor: Re: Reimagining Cancer Staging in the Era of Evolutionary Oncology. | J Natl Compr Canc Netw | 2023 |
| 37010038 | Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management. | J Surg Oncol | 2023 |
| 37072748 | The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022. | J Transl Med | 2023 |
| 37162402 | Mitotic rate in primary cutaneous melanoma: Cell division matters. | Cancer | 2023 |
| 36510640 | Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. | Neuro Oncol | 2023 |
| 36894629 | Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma. | Nature | 2023 |
| 36627494 | Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. | Nature | 2023 |
| 34904258 | Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy. | J Surg Oncol | 2022 |
| 35397739 | An Evidence-Based Staging System for Mucosal Melanoma: A Proposal. | Ann Surg Oncol | 2022 |
| 35705814 | Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. | Nature | 2022 |
| 35583689 | Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts. | Ann Surg Oncol | 2022 |
| 36289334 | Neoadjuvant relatlimab and nivolumab in resectable melanoma. | Nature | 2022 |
| 35810190 | Multi-modal molecular programs regulate melanoma cell state. | Nat Commun | 2022 |
| 36075285 | Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis. | J Am Acad Dermatol | 2022 |
| 35426590 | Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). | Ann Surg Oncol | 2022 |
| 36265502 | Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial. | Lancet Oncol | 2022 |
| 35538491 | The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021. | J Transl Med | 2022 |
| 35921122 | Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial. | JAMA Surg | 2022 |
| 35278716 | Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020. | Pract Radiat Oncol | 2022 |
| 34904258 | Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy. | J Surg Oncol | 2022 |
| 34952092 | Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker. | J Invest Dermatol | 2022 |
| 35089452 | Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC). | Ann Surg Oncol | 2022 |
| 35583689 | Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts. | Ann Surg Oncol | 2022 |
| 35705814 | Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. | Nature | 2022 |
| 35538491 | The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021. | J Transl Med | 2022 |